Intranasal Delivery of Chitosan Nanoparticles for Migraine Therapy.

MLA

Gulati, Neha, et al. “Intranasal Delivery of Chitosan Nanoparticles for Migraine Therapy.” Scientia Pharmaceutica, vol. 81, no. 3, June 2013, pp. 843–54. EBSCOhost, https://doi.org/10.3797/scipharm.1208-18.

APA

Gulati, N., Nagaich, U., & Saraf, S. A. (2013). Intranasal Delivery of Chitosan Nanoparticles for Migraine Therapy. Scientia Pharmaceutica, 81(3), 843–854. https://doi.org/10.3797/scipharm.1208-18

Chicago

Gulati, Neha, Upendra Nagaich, and Shubhini A. Saraf. 2013. “Intranasal Delivery of Chitosan Nanoparticles for Migraine Therapy.” Scientia Pharmaceutica 81 (3): 843–54. doi:10.3797/scipharm.1208-18.